Although no significant changes in the number of CD8+ T cells infiltrating the tumor were observed (data not shown), we found a significantly higher percentage of CD45.1+ IFN-γ producing cells into the tumor of mice treated with CD8-EGFR-GFP as compared to that found in mice treated with control CD8-GFP T cells. The gene discussed is IFNG; the disease is neoplasm.